|
Market Closed -
Nasdaq
04:00:00 2026-01-12 pm EST
|
5-day change
|
1st Jan Change
|
|
106.33 USD
|
-0.51%
|
 |
+4.46%
|
+7.65%
|
|
Jan. 08 |
Incyte Insider Sold Shares Worth $1,184,064, According to a Recent SEC Filing
|
MT
| |
Jan. 07 |
Palvella Therapeutics, Inc. Appoints Vimal Patel as Senior Vice President of Medical Affairs
|
CI
| |
Dec. 12 |
Incyte Insider Sold Shares Worth $554,965, According to a Recent SEC Filing
|
MT
| |
Dec. 12 |
Incyte Corporation Announces Resignation of Hervé Hoppenot from Board of Directors, Effective December 12, 2025
|
CI
| |
Dec. 01 |
Incyte appoints Richard Hoffman as executive vice president and general counsel
|
RE
| |
Dec. 01 |
Incyte Corporation Announces Executive Changes
|
CI
| |
Nov. 07 |
Incyte Insider Sold Shares Worth $534,813, According to a Recent SEC Filing
|
MT
| |
Nov. 05 |
Incyte Insider Sold Shares Worth $289,017, According to a Recent SEC Filing
|
MT
| |
25-10-06 |
Incyte Insider Sold Shares Worth $351,978, According to a Recent SEC Filing
|
MT
| |
25-10-06 |
Maze Therapeutics Appoints Herve Hoppenot as Board Chairman
|
MT
| |
25-10-03 |
Incyte appoints Thomas Tray as principal financial officer - SEC filing
|
RE
| |
25-09-22 |
Incyte Announces the Appointment of Dave Gardner as Executive Vice President and Chief Strategy Officer, Effective September 22, 2025
|
CI
| |
25-08-25 |
Incyte names Soni Basi as Executive Vice President and Chief Human Resources Officer
|
RE
| |
25-08-25 |
Incyte Announces Executive Changes, Effective August 25, 2025
|
CI
| |
25-08-07 |
Incyte Corp - CFO Christiana Stamoulis to step down September 16 - SEC filing
|
RE
| |
25-08-06 |
Mallinckrodt plc Announces Board Changes, Effective September 22, 2025
|
CI
| |
25-08-05 |
Incyte Corporation Announces Departure of Christiana Stamoulis as Executive Vice President, Effective September 16, 2025
|
CI
| |
25-08-05 |
Incyte Corporation Announces Departure of Christiana Stamoulis as Chief Financial Officer, Effective September 16, 2025
|
CI
| |
25-07-29 |
Incyte's new CEO outlines growth plan as Jakafi patent cliff nears
|
RE
| |
25-07-23 |
Incyte Insider Sold Shares Worth $251,786, According to a Recent SEC Filing
|
MT
| |
25-07-07 |
Incyte Insider Sold Shares Worth $743,039, According to a Recent SEC Filing
|
MT
| |
25-07-07 |
Incyte Insider Sold Shares Worth $587,275, According to a Recent SEC Filing
|
MT
| |
25-06-26 |
Incyte Corporation Announces Chief Executive Officer Changes
|
CI
| |
25-06-26 |
Incyte Corporation Announces Management Changes
|
CI
| |
25-06-26 |
Incyte Appoints New CEO
|
MT
|
No results for this search Select your edition All financial news and data tailored to specific country editions | 
